ARCHIVES

RFA On Breast Tumor Factors Patients Survival

This article is from The Cancer Letter archive.

Vol. 06 No. 25 | June 20, 1980

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

NCI expands program to promote healthy diet among African Americans.

September 24, 2004

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy

October 27, 1978

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999